Human C1-esterase inhibitor Withdrawn Phase 2 Trials for Rejection, Transplant / Transplantation, Kidney Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01035593Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation